![]() |
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
Tagged: healthcare, glaxosmithkline, mergers and acquisitions, pfizer, bristol myers squibb, main topics, by industry, carl c icahn, imclone systems, merck and company
ImClone Systems, the biotechnology company controlled by Carl C. Icahn, said a drug maker that proposed a $6.1 billion takeover would make a formal bid or withdraw by the end of the day on Wednesday. Mr. Icahn, ImClone’s chairman and second-biggest shareholder, disclosed on Sept. 10 the offer of $70 a share from a “large pharmaceutical [...] … Continue Reading »